Article List

WPRIM Management System> DCMS> Cancer Research and Treatment> 2003> 35> 3

Volume: 35 Issue: 3

1. Paclitaxel and Cisplatin Combination Chemotherapy in Pretreated Breast Cancer.	Page:267—273
2. Docetaxel and Cisplatin Combination Chemotherapy in Patients with Squamous Cell Carcinomas of the Head and Neck.	Page:261—266
3. Detection of p16(INK4A) in the Mixed Cell Populations of Normal Peripheral Blood Mononuclear Cells and Cervical Cancer Cell Lines.	Page:254—260
4. Clinical Features of Pulmonary Large Cell Neuroendocrine Carcinoma.	Page:245—253
5. A Phase II Study of Paclitaxel and Cisplatin Combination Chemotherapy in Advanced Non-small-cell Lung Cancer.	Page:239—244
6. FDG-PET in Mediastinal Nodal Staging of Non-small Cell Lung Cancer: Correlation of False Results with Histopathologic Finding.	Page:232—238
7. Clinical Pharmacokinetics of Tegafur Administered with Epirubicin and Cisplatin in Patients with Advanced Gastric Cancer.	Page:224—231
8. Prognostic Effect of Vascular Endothelial Growth Factor and Angiogenesis in Gastric Carcinoma.	Page:218—223
9. Gemcitabine and Infusional 5-Fluorouracil in Advanced Pancreatic Cancer: A Clinical Benefit Response-Oriented Phase II Study.	Page:213—217
10. Invasion-Metastasis by Hepatocyte Growth Factor/c-Met Signaling Concomitant with Induction of Urokinase Plasminogen Activator in Human Pancreatic Cancer: Role as Therapeutic Target.	Page:207—212
11. Development of a Conditional Replication Competent Adenovirus, Controlled by the Human Telomerase Promoter (hTERT).	Page:191—206
12. Cell-Specific Growth Inhibition of Human Cervical Cancer Cell by Recombinant Adenovirus p53 in vitro and in vivo.	Page:181—190
13. Treatment of Small Cell Lung Cancer.	Page:177—180
14. Cancer Gene Therapy: Limitations and Progress.	Page:175—176